Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-17

Clinical Trial Update: Combination of Oral and Topical Whitening Agents for Reducing Skin Pigmentation [NA]

View source ↗

Summary

A study is evaluating a combination of oral and topical whitening agents to reduce skin pigmentation (dark spots). The trial status is ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: USMARI Research & Innovation Centre | Conditions: Dark Spots | NA | Status: ACTIVE_NOT_RECRUITING